Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
No Data
Amgen's Blincyto Data Send Cullinan Higher
Seeking Alpha15:39 ET
WHO Picks JN.1 Variant for Next Set of COVID Vaccines
Seeking Alpha14:11 ET
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceApr 27 10:29 ET
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceApr 27 09:48 ET
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Yahoo FinanceApr 27 08:56 ET
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.
Zhitong FinanceApr 27 04:08 ET